The global Anti-VEGF market is gaining significant attention due to the increasing prevalence of retinal disorders, cancer therapies, and chronic eye diseases worldwide. Anti-VEGF therapies are designed to inhibit vascular endothelial growth factor (VEGF), a protein responsible for abnormal blood vessel formation. These treatments are widely used for conditions such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and certain cancers.
https://www.marketresearchfutu....re.com/reports/anti-
Like
Comment
Share
